Cross-source evidence timeline

Cibinetide research timeline

Follow 4 selected, directly cited source records from April 18, 2017 through September 28, 2020. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

4Selected records
3Source years
2Evidence lanes
September 28, 2020Latest source date

Source year

2020

1 record
  1. Literature metadata

    A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.↗

    PubMed lists PMID 32674280 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2020-07-14 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2018

2 records
  1. Literature metadata

    ARA 290 for treatment of small fiber neuropathy in sarcoidosis.↗

    PubMed lists PMID 24555851 in Expert opinion on investigational drugs as Journal Article, Review, with publication-date metadata of 2014-02-21 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception.↗

    PubMed lists PMID 26774587 in Peptides as Journal Article, with publication-date metadata of 2016-01-13 (day precision). PeptideScanner associated the retained record with the identity slug cibinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2017

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT02039687↗

    PeptideScanner retained ClinicalTrials.gov record NCT02039687 at 2026-11-16T01:46:13.488Z. Its registry update date was 2017-04-18, and PeptideScanner's reviewed identity mapping was cibinetide.↗